Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Table 1

Baseline comparisons between the CSII and CSII + Sig groups before treatment.

Characteristic	Group		value
	CSII	CSII + Sig
Patients	30	30	—
Gender (F/M)	15/15	16/14	—
Age (years)	45.18 ± 7.10	46.40 ± 5.14	0.49
Weight (kg)	63.14 ± 6.45	65.99 ± 9.90	0.19
BMI (kg/m^2)	23.56 ± 1.48	23.76 ± 3.01	0.74
HbA1c (%)	10.06 ± 1.82	10.47 ± 1.33	0.32
GA (%)	33.42 ± 4.68	34.11 ± 3.86	0.53
FPG (mmol/L)	10.39 ± 0.96	10.23 ± 0.92	0.50
PPG (mmol/L)	17.97 ± 1.48	18.52 ± 1.45	0.15
FC-P (ng/mL)	1.65 ± 0.59	1.48 ± 0.71	0.32
PC-P (ng/mL)	3.99 ± 2.14	4.20 ± 1.70	0.67
CPI	0.89 ± 0.33	0.82 ± 0.42	0.49
SUIT	2.26 ± 0.84	2.09 ± 1.07	0.49
TC (mmol/L)	5.17 ± 0.72	5.25 ± 0.65	0.69
HDL-C (mmol/L)	1.35 ± 0.29	1.40 ± 0.27	0.50
LDL-C (mmol/L)	2.78 ± 0.64	2.90 ± 0.77	0.51
Tg (mmol/L)	1.94 ± 0.62	2.06 ± 0.96	0.57

Note: data are presented as the means ± SD. CSII group: CSII monotherapy group; CSII + Sig group: CSII therapy in combination with sitagliptin group; GA: glycated albumin; FPG: fasting plasma glucose; PPG: postprandial plasma glucose; FC-P: fasting C-peptide; PC-P: 2-h postprandial C-peptide; CPI: C-peptide reactivity index; SUIT: secretory unit of islet in transplantation index; TC: total cholesterol; Tg: triglycerides; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein-cholesterol.